TELVELZO
Live / Applied — New application — not yet assigned to an examiner (as of 02 Feb 2026)
What this means for you
Not registered yet, but its 02 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99628002
- Mark type
- Stylized text
- Filed
- 02 Feb 2026
- Attorney of record
- Leonard D. Bowersox
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of blood disorders; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders, and blood-based diseases; pharmaceutical preparations for cell and gene therapy for the treatment of blood cells, blood disorders and blood-based diseases and to be infused to a human subject; pharmaceutical preparations for cell and gene therapy for the treatment of bone marrow; pharmaceutical preparations containing cells treated with vectors encoding proteins for elongating telomeres in blood cells; pharmaceutical preparations containing blood cells treated with vectors encoding ZSCAN4 proteins for elongating telomeres in the blood cells; pharmaceutical preparations containing blood cells treated with Sendai virus vectors encoding proteins for elongating telomeres in the blood cells
Owner
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
Prosecution history
- 02 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 02 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Feb 2026 — NEW APPLICATION ENTERED